IL-6 INHIBITORS AND JAK INHIBITORS: WHICH OF THESE DRUGS, INHIBITING A COMMON PATHWAY, HAS AN ADVANTAGE IN PREVENTING BONE DESTRUCTION IN RA?

被引：0

作者：

Koyama, Y. ^{[1
]}

Sato, Y. ^{[2
]}

Sakamoto, M. ^{[1
]}

Nakai, Y. ^{[1
]}

机构：

[1] Japanese Red Cross Okayama Hosp, Div Rheumatol, Ctr Autoimmune Dis, Okayama, Japan

[2] DNA Chip Res Inc, Med Lab, Tokyo, Japan

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

bDMARD; Targeted synthetic drugs; Rheumatoid arthritis;

D O I：

10.1136/annrheumdis-2023-eular.2872

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0311

引用

页码：400 / 400

页数：1

共 3 条

[1] Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions [J].

Komatsu, Noriko ;

Takayanagi, Hiroshi .

NATURE REVIEWS RHEUMATOLOGY, 2022, 18 (07) :415-429

[2] Osteoclast biology in the single-cell era [J].

Tsukasaki, Masayuki ;

Takayanagi, Hiroshi .

INFLAMMATION AND REGENERATION, 2022, 42 (01)

[3] ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts [J].

Yan, Minglu ;

Komatsu, Noriko ;

Muro, Ryunosuke ;

Huynh, Nam Cong-Nhat ;

Tomofuji, Yoshihiko ;

Okada, Yukinori ;

Suzuki, Hiroshi, I ;

Takaba, Hiroyuki ;

Kitazawa, Riko ;

Kitazawa, Sohei ;

Pluemsakunthai, Warunee ;

Mitsui, Yuichi ;

Satoh, Takashi ;

Okamura, Tadashi ;

Nitta, Takeshi ;

Im, Sin-Hyeog ;

Kim, Chan Johng ;

Kollias, George ;

Tanaka, Sakae ;

Okamoto, Kazuo ;

Tsukasaki, Masayuki ;

Takayanagi, Hiroshi .

NATURE IMMUNOLOGY, 2022, 23 (09) :1330-+

← 1 →